A study on which kind of hemostatic sponges has a more effective hemostatic effect for patients taking posterior spinal fusion surgeries

ISRCTN ISRCTN29254316
DOI https://doi.org/10.1186/ISRCTN29254316
Secondary identifying numbers N/A
Submission date
14/10/2016
Registration date
25/10/2016
Last edited
18/11/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Lumbar stenosis is a condition where there is a narrowing of the spinal canal (space in the spine that the spinal cord travels through) in the lower back. This narrowing puts pressure on the nerves that make up the spinal cord leading to pain in the legs. In some patients, the pain can be so severe that it can prevent them from walking and surgery is the main treatment option. Patients undergoing surgery on the spine are at risk of losing large quantities of blood during the surgery. This may lead to the need for blood transfusions after surgery which can extend their stay in hospital. Stablising blood flow during surgery is an important way of controlling blood loss and being able to perform the surgery well. In recent years, use of certain types of sponges have been a good way for controlling blood loss, however it is not known which is the most effective. The aim of this study is to compare the effectiveness of three different haemostatic (blood controlling) sponges on blood loss in spinal surgery patients.

Who can participate?
Patients with spinal stenosis who are suitable for spinal surgery.

What does the study involve?
Participants are randomly allocated to one of three groups. All patients are treated using standard surgical techniques and have their bleeding controlled by having the blood vessels that have been cut during surgery sealed off. They then have a sponge placed on the area which is either made from gelatin, or one of two types of cellulose (a plant material). Participants in all groups are then followed up for 48 hours after surgery to monitor blood loss.

What are the possible benefits and risks of participating?
Participants in all groups should benefit from lower levels of bleeding after surgery. There are no direct risks involved with participating.

Where is the study run from?
Peking Union Medical College Hospital (China)

When is the study starting and how long is it expected to run for?
November 2013 to December 2016

Who is funding the study?
Wuxi Biot Bio-technology co. Ltd (China)

Who is the main contact?
Mr Shugang Li

Contact information

Mr Shugang Li
Public

Department of Orthorpaedic Surgery
Peking Union Medical College Hospital
No.1 Shuai Fu Yuan
Wang Fu Jing Street
BeiJing
100170
China

Study information

Study designThree-arm randomised parallel trial
Primary study designInterventional
Secondary study designRandomised parallel trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet No participant information sheet available
Scientific titleA randomized parallel trial on effects of different hemostatic sponges in posterior spinal fusion surgeries
Study hypothesisThe aim of this study is to assess the impact of three different hemostatic materials on operative blood loss in spinal fusion surgery.
Ethics approval(s)Peking Union Medical College Hospital Ethics Committee, 11/06/2014, ref: HS2014046
ConditionSpinal surgery
InterventionParticipants are randomly allocated to one of three groups using a simple equal probability randomization scheme. All participants undergo posterior lumbar decompression, internal fixation or bone graft fusion surgery by the same surgeon using standard techniques.

Group A: Following decompression post-operative bleeding is controlled using bipolar electrocautery, after which a Stypro hemostatic sponge is placed on the surface of the spinal dura mater.
Group B: Following decompression post-operative bleeding is controlled using bipolar electrocautery, after which a Collagen hemostatic sponge is placed on the surface of the spinal dura mater.
Group C: Following decompression post-operative bleeding is controlled using bipolar electrocautery, after which a Gelatin sponge is placed on the surface of the spinal dura mater.

Participants are followed up for 48 hours after surgery.
Intervention typeProcedure/Surgery
Primary outcome measurePostoperative drainage is measured using a measuring cylinder over the first 24 hours after surgery, the second 24 hours after surgery.
Secondary outcome measuresIntraoperative estimated blood loss (EBL) is calculated on the basis of surgical sponges soaked and volume in suction canisters, subtracting irrigation fluid added to the surgical field immediately after surgery.
Overall study start date01/11/2013
Overall study end date01/12/2016

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants50
Participant inclusion criteria1. Lumbar stenosis
2. Disc disease
3. Instability (e.g. grade I-II spondylolisthesis, spondylolisthesis /spondylolysis)
4. Indicated for spinal surgeries
5. Aged 50 years and over
Participant exclusion criteria1. Severe medical comorbidities such as osteoporosis, anemia and cardiovascular disease
2. Involvement of more than three surgical levels
3. Patients had abnormal prothrombin time (PT), partial thromboplastin time (PTT) and International Normalized Ratio (INR)
4. Patients were taking anti-platelet aggregates such as Aspirin or other anticoagulants
Recruitment start date30/06/2014
Recruitment end date01/03/2015

Locations

Countries of recruitment

  • China

Study participating centre

Peking Union Medical College Hospital
No.1 Shuai Fu Yuan, Wang Fu Jing Street, Beijing, China.
Beijing
100170
China

Sponsor information

Peking Union Medical College Hospital
Hospital/treatment centre

Department of Orthorpaedic Surgery
No.1 Shuai Fu Yuan
Wang Fu Jing Street
Beijing
100730
China

Website http://www.pumch.cn/Index.html
ROR logo "ROR" https://ror.org/04jztag35

Funders

Funder type

Industry

Wuxi Biot Bio-technology co. Ltd

No information available

Results and Publications

Intention to publish date01/12/2017
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Derong Xu (xuderong19880001@163.com)

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Basic results 15/10/2016 26/10/2016 No No
Results article 12/12/2016 18/11/2024 Yes No

Additional files

ISRCTN29254316_BasicResults_15Oct2016.docx
Uploaded 26/10/2016

Editorial Notes

18/11/2024: Publication reference added.
26/10/2016: The basic results summary file has been uploaded.